Friday, August 3, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news
 
New rules on pharmaceutical excipients to stem malpractice: SFDA
Xinhua
BEIJING, Aug. 3 (Xinhua) -- A senior medical official on Friday expressed confidence that a new regulation will prevent malpractice and help regulate the pharmaceutical market. Yin Li, director of the State Food and Drug Administration (SFDA), said the new ...
See all stories on this topic »
UK drug price negotiations to begin next month
Reuters India
LONDON (Reuters) - The British government and the pharmaceutical industry will start negotiations next month on a new framework for pricing drugs that is due to take effect from 2014, the two sides said on Friday. Health minister Andrew Lansley has ...
See all stories on this topic »
Catalyst Pharmaceutical Partners Regains Compliance With NASDAQ Minimum ...
MarketWatch (press release)
CORAL GABLES, Fla., Aug 3, 2012 (GlobeNewswire via COMTEX) -- Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) announced today that it has received notice from the NASDAQ Stock Market ("NASDAQ") confirming that the Company has ...
See all stories on this topic »
Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
Sacramento Bee
2, 2012 -- /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported ...
See all stories on this topic »
Sun Pharmaceutical Considers Buying Germany's Stada – Report
Wall Street Journal (India) (blog)
Indian drugmaker Sun Pharmaceutical Industries Ltd. is considering making a European acquisition and might buy Germany's Stada Arzneimittel AG, Bloomberg News reported Thursday, citing people familiar with the matter. Sun, the largest drugmaker in ...
See all stories on this topic »
High profit and growth feature at Israel's Taro Pharmaceutical
Emerging Money
Taro Pharmaceutical Industries (TARO, quote) is a drug company with a high profit margin and high sales growth for those looking to gain from the expansion of the global consumer class. Based in Haifa Bay, Taro is a: "science-based pharmaceutical ...
See all stories on this topic »
Teva Pharmaceutical Industries a Top Ranked SAFE Dividend Stock With 2.5 ...
Forbes
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has been named to the Dividend Channel "International S.A.F.E. 10" list, signifying an international stock with above-average "DividendRank" statistics including a strong 2.5% yield, as well as a superb track ...
See all stories on this topic »
Report: Generic drugs saved $193 billion in 2011
Businessweek
The fourth annual report, produced for the Generic Pharmaceutical Association, found use of generic prescription drugs in the U.S. saved about $193 billion last year alone. That amount was up 22 percent from the $158 billion in savings from generics in 2010, ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

0 comments:

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost